Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes.

Abstract

Cardiac myocytes contain functional estrogen receptors, however, the effect of estrogen on growth-related signaling pathways such as mitogen-activated protein kinases (MAPK) in the pathogenesis of cardiac disease is unclear. MAPKs are critically involved in regulatory signaling pathways which ultimately lead to cardiac hypertrophy. Here we show that 17beta-estradiol (E2) activates extracellular signal-regulated kinase (ERK1/2), c-Jun-NH2-terminal protein kinase (JNK) and p38 in rat cardiomyocytes in a distinctive pattern. As shown by immunoblot analysis and phosphorylation assays, E2 (10(-9) M) induced a rapid and transient activation of ERK1/2 and a rapid but sustained increase of JNK phosphorylation. In contrast, E2 had only a marginal effect on p38 activation. Furthermore, MAPK phosphatase expression was induced by E2 and E2-stimulated expression of endothelial and inducible NO synthase was inhibited by PD 98059, an inhibitor of the ERK pathway. These novel observations may help to explain the role of estrogen in gender-based differences found in cardiac disease.

• Authors: S Nuedling, S Kahlert, K Loebbert, R Meyer, H Vetter, C Grohé
• Journal: FEBS letters (FEBS Lett) Vol. 454 Issue 3 Pg. 271-6 (Jul 09 1999) ISSN: 0014-5793 [Print] England
• PMID: 10431821 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Estradiol
• Protein Kinases
• Calcium-Calmodulin-Dependent Protein Kinases
• JNK Mitogen-Activated Protein Kinases
• MAP Kinase Kinase 4
• Mitogen-Activated Protein Kinase Kinases

Topics

• Animals
• Calcium-Calmodulin-Dependent Protein Kinases (metabolism)
• Estradiol (pharmacology)
• Female
• JNK Mitogen-Activated Protein Kinases
• MAP Kinase Kinase 4
• Mitogen-Activated Protein Kinase Kinases
• Myocardium (metabolism)
• Phosphorylation
• Protein Kinases (metabolism)
• Rats
• Rats, Inbred WKY
• Signal Transduction (drug effects)